PMID- 33983389 OWN - NLM STAT- MEDLINE DCOM- 20211029 LR - 20211029 IS - 1537-6591 (Electronic) IS - 1058-4838 (Linking) VI - 73 IP - 8 DP - 2021 Oct 20 TI - Development of the Three Antimicrobial Stewardship E's (TASE) Framework and Association Between Stewardship Interventions and Intended Results Analysis to Identify Key Facility-Specific Interventions and Strategies for Successful Antimicrobial Stewardship. PG - 1397-1403 LID - 10.1093/cid/ciab430 [doi] AB - BACKGROUND: Successful antimicrobial stewardship (AS) interventions have been described previously. Currently, a uniform operational approach to planning and implementing successful AS interventions does not exist. From 2015 to 2019, concomitant vancomycin and piperacillin-tazobactam use (CVPTU) for >48 hours at Vanderbilt University Medical Center (VUMC) significantly decreased through AS efforts. We analyzed the interventions that led to this change and created a model to inform future intervention planning and development. METHODS: Adult admissions at VUMC from January 2015 to August 2019 were evaluated for CVPTU. The percentage of admissions receiving CVPTU for >48 hours, the primary outcome, was evaluated using statistical process control charts. We created the Three Antimicrobial Stewardship E's (TASE) framework and Association between Stewardship Interventions and Intended Results (ASIR) analysis to assess potential intensity and impact of interventions associated with successful change during this time period and to identify guiding principles for development of future initiatives. RESULTS: The mean percentage of admissions receiving CVPTU per month declined from 4.2% to 0.7%. Over 8 time periods, we identified 4 periods with high, 3 with moderate, and 1 with low intervention intensity. Continuous provider-level AS education was present throughout. Creation and dissemination of division and department algorithms and reinforcement via computerized provider order entry sets preceded the largest reduction in CVPTU and sustained prescribing practice changes. CONCLUSIONS: The TASE framework and ASIR analysis successfully identified pivotal interventions and strategies needed to effect and sustain change at VUMC. Further research is needed to validate the effectiveness of this framework as a stewardship intervention planning tool at our institution and others. CI - (c) The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. FAU - Kimball, Joanna M AU - Kimball JM AUID- ORCID: 0000-0001-6020-8047 AD - Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA. FAU - Deri, Connor R AU - Deri CR AD - Antimicrobial Stewardship and Pharmacy, Vanderbilt University Medical Center, Nashville, Tennessee, USA. FAU - Nesbitt, Whitney J AU - Nesbitt WJ AD - Antimicrobial Stewardship and Pharmacy, Vanderbilt University Medical Center, Nashville, Tennessee, USA. FAU - Nelson, George E AU - Nelson GE AD - Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA. FAU - Staub, Milner B AU - Staub MB AD - Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA. AD - Geriatric Research Education and Clinical Center, VA Tennessee Valley Healthcare System, Nashville, Tennessee, USA. LA - eng PT - Journal Article PT - Research Support, U.S. Gov't, Non-P.H.S. PL - United States TA - Clin Infect Dis JT - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America JID - 9203213 RN - 0 (Anti-Bacterial Agents) RN - 157044-21-8 (Piperacillin, Tazobactam Drug Combination) RN - 6Q205EH1VU (Vancomycin) SB - IM MH - Adult MH - Anti-Bacterial Agents/therapeutic use MH - *Antimicrobial Stewardship MH - Hospitalization MH - Humans MH - Piperacillin, Tazobactam Drug Combination MH - Vancomycin OTO - NOTNLM OT - antimicrobial stewardship OT - antimicrobial stewardship framework OT - antimicrobial stewardship intervention OT - quality improvement EDAT- 2021/05/14 06:00 MHDA- 2021/10/30 06:00 CRDT- 2021/05/13 12:34 PHST- 2021/02/03 00:00 [received] PHST- 2021/05/14 06:00 [pubmed] PHST- 2021/10/30 06:00 [medline] PHST- 2021/05/13 12:34 [entrez] AID - 6275287 [pii] AID - 10.1093/cid/ciab430 [doi] PST - ppublish SO - Clin Infect Dis. 2021 Oct 20;73(8):1397-1403. doi: 10.1093/cid/ciab430.